Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Biohaven Therapeutics Ltd.

Clinical trials sponsored by Biohaven Therapeutics Ltd., explained in plain language.

Biohaven Therapeutics Ltd. BHVN NYSE

A biopharmaceutical company focused on neuroscience and immunology.

Trade on eToro (ad)

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Trials to join now! 7 Not yet recruiting 1 Not yet finished but already full! 5 Completed 4 Terminated 2

New drug BHV-1400 aims to protect kidneys in IgA nephropathy

Disease control Not yet recruiting

This Phase 3 trial tests whether BHV-1400 can safely reduce protein in the urine and preserve kidney function in 420 adults with IgA nephropathy. Participants are randomly assigned to receive either the drug or a placebo by injection. The main goal is to see if BHV-1400 lowers pr…

Phase: PHASE3 • Sponsor: Biohaven Therapeutics Ltd. • Aim: Disease control

Last updated Jun 27, 2026 13:07 UTC